Safety and Efficacy of Klotho and Follistatin Gene Therapy
ConditionHealthy Adults
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age50-80
SponsorMinicircle
About this trial
The purpose of this study is to investigate the safety and efficacy of a combination klotho and follistatin gene therapy, delivered via a nonviral plasmid in healthy adult volunteers. Additionally, this study seeks to understand the cognitive and health benefits of this gene therapy.
Eligibility criteria
Qualifiers
Adults aged 50 to 80 years
General good health
Willing to comply with all study-related procedures and visits
Participant is open to morphological change
Disqualifiers
Currently enrolled in another clinical trial
History of cancer, autoimmune disease, or chronic kidney/liver disease
Use of immunosuppressive therapy
Pregnant or breastfeeding
Trial design
Treatments tested in this trial
- Follistatin and klotho gene therapy
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov